Showing 8,521 - 8,540 results of 20,793 for search '"Therapy"', query time: 0.13s Refine Results
  1. 8521

    Ovarian Vein Thrombosis Complicated by Pulmonary Embolism after Cesarean Delivery in the Presence of a Large Fibroid: Case Report and Literature Review of Contributing Factors by Elie S. Finianos, Stephanie F. Yacoub, Mary F. Chammas

    Published 2021-01-01
    “…Following initiation of anticoagulation therapy, she developed dyspnea and testing showed a subsegmental pulmonary embolism. …”
    Get full text
    Article
  2. 8522

    Motion – The Available Treatments for Hepatitis C Are Cost Effective: Arguments against the Motion by W Ray Kim

    Published 2002-01-01
    “…In contrast, antiviral therapy is more effective in young and female patients and those who do not drink alcohol. …”
    Get full text
    Article
  3. 8523

    Urothelial Cancer Stem Cells by Irena Dimov, Milan Visnjic, Vladisav Stefanovic

    Published 2010-01-01
    “…There is mounting evidence supporting the idea that tumors, similar to normal adult tissues, arise from a specific stem-like cell population, the cancer stem cells (CSCs), which are considered as the real driving force behind tumor growth, the ability to metastasize, as well as resistance to conventional antitumor therapy. The concept that cancer growth recapitulates normal proliferative and/or regenerative processes, even though in very dysfunctional ways, has tremendous implications for cancer therapy. …”
    Get full text
    Article
  4. 8524

    Metachronous Liver Metastasis from Alpha-Fetoprotein-Producing Gastric Cancer Successfully Treated with Capecitabine/Oxaliplatin Combination Chemotherapy by Soichi Furukawa, Takashi Kobayashi, Saori Shiono, Shuta Nishinakagawa

    Published 2022-01-01
    “…This case demonstrates that combined capecitabine and oxaliplatin therapy can successfully treat metachronous liver metastasis from alpha-fetoprotein-producing gastric carcinoma.…”
    Get full text
    Article
  5. 8525

    Advances in sodium-glucose transporter protein 2 inhibitors and tumors by Jiaqi Wang, Wenyong Yang

    Published 2025-02-01
    “…Although the clinical application of targeted therapy and immunotherapy has improved the status quo of tumor treatment, the development of new therapeutic tools for tumors is still necessary. …”
    Get full text
    Article
  6. 8526

    The Domestic Cat as a Large Animal Model for Characterization of Disease and Therapeutic Intervention in Hereditary Retinal Blindness by Kristina Narfström, Koren Holland Deckman, Marilyn Menotti-Raymond

    Published 2011-01-01
    “…Therapeutic trials have been performed mainly in the former type including stem cell therapy, retinal transplantation, and development of ocular prosthetics. …”
    Get full text
    Article
  7. 8527

    Factors Affecting Vagus Nerve Stimulation Outcomes in Epilepsy by Mehdi Abbasi, Atie Moghtadaie, Seyed Amir Miratashi Yazdi

    Published 2021-01-01
    “…One-third of patients do not respond to medical treatments requiring alternative therapies. Vagus nerve stimulation (VNS) has been used in the last decades for the treatment of medically resistant epilepsy. …”
    Get full text
    Article
  8. 8528

    Epidermal Growth Factor Receptor Gene in Non-Small-Cell Lung Cancer: The Importance of Promoter Polymorphism Investigation by Vladimir Jurišić, Jasmina Obradovic, Sonja Pavlović, Nataša Djordjevic

    Published 2018-01-01
    “…The accumulation of knowledge regarding SNPs lately suggests their significant and important role in the onset of carcinogenesis, the prediction of the onset of metastases, the response to therapy with TKI inhibitors, and the onset of toxic effects of the applied therapy. …”
    Get full text
    Article
  9. 8529

    Chronic Disseminated Candidiasis Complicated by Immune Reconstitution Inflammatory Syndrome in Child with Acute Lymphoblastic Leukemia by Olga Zając-Spychała, Bogna Ukielska, Katarzyna Jończyk-Potoczna, Benigna Konatkowska, Jacek Wachowiak

    Published 2016-01-01
    “…Despite proper antifungal therapy, there was no clinical and radiological improvement, so diagnosis of Candida-related IRIS was made and corticosteroid therapy was added to antifungal treatment achieving prompt resolution of infection symptoms.…”
    Get full text
    Article
  10. 8530
  11. 8531

    Systemic Treatment of Vitreous Inflammation by John B. Christoforidis, Susie Chang, Angela Jiang, Jillian Wang, Colleen M. Cebulla

    Published 2012-01-01
    “…Each class of systemic therapy for non-infectious vitreous inflammation is reviewed. …”
    Get full text
    Article
  12. 8532

    Mesenchymal Stem Cells: A Potential Therapeutic Approach for Amyotrophic Lateral Sclerosis? by Agnese Gugliandolo, Placido Bramanti, Emanuela Mazzon

    Published 2019-01-01
    “…For this reason, more studies and trials are needed to clarify the real effectiveness of MSC-based therapy in ALS.…”
    Get full text
    Article
  13. 8533

    Development of Asymmetric Facial Depigmentation in a Patient Treated with Dasatinib with New-Onset Hypovitaminosis D: Case Report and Review of the Literature by Kirsten C. Webb, Magdalena Harasimowicz, Monica Janeczek, Jodi Speiser, James Swan, Rebecca Tung

    Published 2017-01-01
    “…While the most commonly reported cutaneous side effects with this therapy include a morbilliform eruption, skin exfoliation, and skin irritation, pigmentary abnormalities have also been observed, albeit much more rarely. …”
    Get full text
    Article
  14. 8534

    Treatment of arrhythmogenic right ventricular cardiomyopathy (dysplasia) by M.Т. Vatutin, G.S. Smyrnova, Y.V. Yeshchenko, G.E. Degtiarova, V.S. Kolesnikov, Y.P. Gritsenko

    Published 2016-03-01
    “…The information about risk stratification, follow-up, lifestyle changes, pharmacological therapy, catheter ablation, implantable defibrillator therapy and heart transplantation is given in detail.…”
    Get full text
    Article
  15. 8535

    The interpretation of Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update by LU Yujie, ZHU Siji

    Published 2024-09-01
    “…The new “2022 version Guideline” suggested that the use of BP should be discussed for all postmenopausal patients with early breast cancer who are indicated for adjuvant therapy. Recommended drugs included zoledronate, clodronate, and ibandronate, and the recommended duration of BP was 2-3 years. …”
    Get full text
    Article
  16. 8536

    Investigation of hemostasis by thromboelastography in the patient with liver cirrhosis (Clinical case) by Ye. L. Bulanova, A. Yu. Bulanov, D. S. Gatsolayeva

    Published 2011-12-01
    “…Intravenous infusion therapy required installation of central venous catheter, that was complicated by catheter bleeding. …”
    Get full text
    Article
  17. 8537

    Atypical presentation of anorexia nervosa pediatric patient: A multidisciplinary approach to diagnosis and management by Zainab Al Masseri, Afnan Aljawad, Zahrah Alkashi, Nadeer Albaik

    Published 2025-01-01
    “…This case report describes the complex presentation, diagnostic problems, and multidisciplinary therapy of a 13-year-old Syrian girl with an unusual form of anorexia nervosa (AN). …”
    Get full text
    Article
  18. 8538

    Chinese guidelines for the diagnosis and treatment of human immunodeficiency virus infection/acquired immunodeficiency syndrome (2024 edition) by Acquired Immunodeficiency Syndrome Professional Group, Society of Infectious Diseases, Chinese Medical Association; Chinese Center for Disease Control and Prevention, Wei Zhao

    Published 2025-01-01
    “…The 2024 edition of the Guidelines has been compiled by updating the 2021 fifth edition, incorporating the latest research advancements in antiviral therapy, comprehensive management, opportunistic infections, concurrent tumors, and the prevention and intervention of HIV infection. …”
    Get full text
    Article
  19. 8539
  20. 8540

    Clinical Experience with 5-Aminosalicylate Preparations in Inflammatory Bowel Disease - A Review by C.N. Williams

    Published 1987-01-01
    “…When oral 5-ASA is compared with conventional oral sulfasalazine therapy, the efficacy is comparable. However, with 5-ASA the incidence of side effects is considerably lower; the number of patients discontinuing therapy is less; patient compliance is better, especially for the long term; dosage increase following inadequate action is more readily possible; and bacterial activation of the drug given is not necessary.…”
    Get full text
    Article